Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Immuneering (IMRX) Other Operating Expenses (2022 - 2026)

Immuneering's Other Operating Expenses history spans 5 years, with the latest figure at $7317.0 for Q1 2026.

  • On a quarterly basis, Other Operating Expenses changed 0.0% to $7317.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $29268.0, a 0.0% change, with the full-year FY2025 number at $29267.0, changed 0.0% from a year prior.
  • Other Operating Expenses came in at $7317.0 for Q1 2026, roughly flat from $7317.0 in the prior quarter.
  • The five-year high for Other Operating Expenses was $8103.0 in Q1 2022, with the low at $7316.0 in Q4 2022.
  • Historically, Other Operating Expenses has averaged $7363.2 across 5 years, with a median of $7317.0 in 2022.
  • Peak annual rise in Other Operating Expenses hit 0.01% in 2023, while the deepest fall reached 9.7% in 2023.
  • Year by year, Other Operating Expenses stood at $7316.0 in 2022, then grew by 0.01% to $7317.0 in 2023, then changed by 0.0% to $7317.0 in 2024, then changed by 0.0% to $7317.0 in 2025, then changed by 0.0% to $7317.0 in 2026.
  • Business Quant data shows Other Operating Expenses for IMRX at $7317.0 in Q1 2026, $7317.0 in Q4 2025, and $7317.0 in Q3 2025.